Advertisement

Reactions Weekly

, Volume 1187, Issue 1, pp 1–1 | Cite as

Increased haemorrhage risk with idraparinux leads to trial termination

Clinical study
  • 8 Downloads

Keywords

Atrial Fibrillation Warfarin Renal Impairment Acenocoumarol Antagonist Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    Amadeus Investigators.Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 371: 315-321, No. 9609, 26 Jan 2008Google Scholar

Copyright information

© Adis International limited or Adis Data Information BV 2008

Personalised recommendations